Meta-analysis
Published: Apr 2018
ACE Report #10252

Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls
Study Type:Meta-analysis/Systematic Review
OE Level Evidence:1
Journal Level of Evidence:N/A
Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and metaanalysis
Expert Opin Drug Saf. 2018 Apr;17(4):413-428Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
To view the full report, start your 30-day free trial today
No credit card required
JOIN LOGIN Forgot Password?Explore some of our unlocked reports below!

Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE
Please Login or Join to leave comments.